Qamar T, Levy R A, Sammaritano L, Gharavi A E, Lockshin M D
Division of Rheumatic Diseases, Hospital for Special Surgery, New York, New York.
Arthritis Rheum. 1990 Apr;33(4):501-4. doi: 10.1002/art.1780330406.
Although high-titer IgG antiphospholipid antibody (aPL) is a predictor of mid-pregnancy fetal death in women with systemic lupus erythematosus (SLE), some SLE patients with high-titer aPL carry pregnancies normally, and to term. To determine potential antibody differences between IgG aPL-positive women with and without fetal death, we studied aPL isotype, subclass, anticoagulant activity, phospholipid specificity, and antibody avidity in selected sera from pregnant SLE patients with high-titer IgG aPL. For controls, we selected sera from pregnant SLE patients who had negative results on tests for IgG aPL (with and without fetal loss). None of the specified antibody characteristics distinguished between the aPL-positive patient groups, nor were other specificities defined in IgG aPL-negative sera from women with fetal death. Although high-titer aPL is a good predictor of fetal death, currently known characteristics, other than a high titer of aPL, do not identify which women will experience this complication.
尽管高滴度IgG抗磷脂抗体(aPL)是系统性红斑狼疮(SLE)女性孕中期胎儿死亡的一个预测指标,但一些高滴度aPL的SLE患者妊娠过程正常并足月分娩。为了确定有或没有胎儿死亡的IgG aPL阳性女性之间潜在的抗体差异,我们研究了高滴度IgG aPL的妊娠SLE患者选定血清中的aPL同种型、亚类、抗凝活性、磷脂特异性和抗体亲和力。作为对照,我们选择了IgG aPL检测结果为阴性(有或没有胎儿丢失)的妊娠SLE患者的血清。所指定的抗体特征均无法区分aPL阳性患者组,胎儿死亡女性的IgG aPL阴性血清中也未定义其他特异性。尽管高滴度aPL是胎儿死亡的良好预测指标,但除了高滴度aPL外,目前已知的特征无法识别哪些女性会发生这种并发症。